港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医美概念股

685.285

-31.956-4.46%

涨家数：1

跌家数：6

平家数：6

市盈率：- -

高：696.344

开：678.885

低：675.692

收：717.241

数据加载中...

总览新闻资讯

德镁医药拟登陆联交所主板专注皮肤健康领域创新

现代牙科(03600)4月24日斥资42.34万港元回购10万股

四环医药04月24日获主力加仓241万元

复星医药04月24日主力净流入177万元散户资金抛售

时代天使04月24日主力净流出1万元散户资金买入

三生制药04月24日主力净流入4482万元散户资金抛售

四环医药涨超3%惠升生物研发的达格列净片获国家药监局上市批准

港股异动 | 四环医药(00460)涨超3% 惠升生物研发的达格列净片获国家药监局上市批准

三生制药盘中异动早盘股价大涨5.00%

康哲药业(00867)拟分拆德镁医药上市，业务聚焦推动估值提升

康哲药业分拆“德镁医药”赴港介绍上市，专业聚焦皮肤健康创新药企业

四环医药：惠升生物研发的达格列净片获国家药监局上市批准

四环医药(00460)：惠升生物研发的达格列净片获国家药监局上市批准

现代牙科回购10万股金额43万港元

现代牙科(03600)4月23日耗资约42.78万港元回购10万股

复星医药(02196)：李东久辞去高级副总裁职务

复锐医疗科技高管团队一行到访星荣医院研讨共筑医美产学研医创新高地

每日卖空追踪 | 康哲药业 04月23日卖空量成交279.8万股，卖空比例为11.89%

康哲药业分拆“德镁医药”，来自海南海口，拟以介绍方式赴香港上市，递交上市申请

港股异动 | 时代天使(06699)涨超4% 公司股东李华敏收购上海恺皓40%股权

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1593/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":685.285,"timestamp":1745819821232,"preClose":717.24054,"halted":0,"volume":109798638,"delay":0,"changeRate":-0.044553,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-31.955566,"latestTime":"04-28 13:57:01","open":678.8851,"high":696.34436,"low":675.6922,"amount":1061892782,"amplitude":0.028794,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1745827800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745803800000,1745812800000],[1745816400000,1745827200000]],"pbRate":1.255448,"peRate":19.315719,"turnoverRate":0.005491,"increases":1,"decrements":6,"flats":6,"marketCap":118070423592,"floatMarketCap":82130255784},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":696.34436,"amplitude":0.028794,"preClose":717.24054,"low":675.6922,"pbRate":"1.255448","latestPrice":685.285,"volume":109798638,"delay":0,"open":678.8851,"prevYearClose":571.87146,"prevWeekClose":717.241,"prevMonthClose":677.607,"prevQuarterClose":677.607,"fiveDayClose":661.02,"twentyDayClose":662.617,"sixtyDayClose":538.937,"secType":"PLATE","market":"HK","turnoverRate":0.005491,"peRate":19.315719,"marketCap":118070423592,"floatMarketCap":82130255784,"timestamp":1745819821232,"nameCN":"医美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":1,"down":6,"flat":6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529609393","title":"德镁医药拟登陆联交所主板 专注皮肤健康领域创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2529609393","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529609393?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 18:18","pubTimestamp":1745489882,"startTime":"0","endTime":"0","summary":"4月22日，德镁医药有限公司向香港联交所递交上市申请，计划以介绍方式在主板挂牌，华泰国际担任独家保荐人。同日，其母公司康哲药业宣布拟分拆德镁医药独立上市，将通过实物分派方式向股东分配所持德镁医药股份。德镁医药是一家专注于皮肤健康的创新型医药企业，覆盖皮肤处方药及护肤品的研发、生产与销售。财务数据显示，2022年至2024年，德镁医药收入逐年增长，但同期净利润波动较大，毛利率介于63.5%至76.9%之间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042418214697436a42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042418214697436a42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015986.USD","BK1515","SG9999015978.USD","BK1161","SG9999015952.SGD","09939","BK1593","IE00BMCWC346.EUR","LU2488822045.USD","BK1191","BK1574","00867","SG9999004220.SGD","IE00BYV24P56.USD","SG9999015945.SGD"],"gpt_icon":0},{"id":"2529679077","title":"现代牙科(03600)4月24日斥资42.34万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529679077","media":"智通财经","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529679077?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 17:16","pubTimestamp":1745486203,"startTime":"0","endTime":"0","summary":"智通财经APP讯，现代牙科(03600)发布公告，于2025年4月24日该公司斥资42.34万港元回购10万股，回购价格为每股4.21-4.26港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1100","BK1593","03600"],"gpt_icon":0},{"id":"2529676238","title":"四环医药04月24日获主力加仓241万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529676238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529676238?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 16:16","pubTimestamp":1745482616,"startTime":"0","endTime":"0","summary":"04月24日, 四环医药股价涨1.54%，报收0.66元，成交金额2111万元，换手率0.35%，振幅6.15%，量比1.26。四环医药今日主力资金净流入241万元，连续3日净流入，上一交易日主力净流入51万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为62.50%，平均涨幅为3.49%。该股近5个交易日上涨3.13%，主力资金累计净流入1407万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入3016万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424170419a4651948&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424170419a4651948&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","BK1191","BK1515","00460","BK1593"],"gpt_icon":0},{"id":"2529675801","title":"复星医药04月24日主力净流入177万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529675801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529675801?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 16:16","pubTimestamp":1745482590,"startTime":"0","endTime":"0","summary":"04月24日, 复星医药股价涨1.09%，报收14.80元，成交金额9384万元，换手率1.17%，振幅4.10%，量比1.84。复星医药今日主力资金净流入177万元，上一交易日主力净流出283万元。该股近5个交易日上涨2.66%，主力资金累计净流出187万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入838万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424170154a465186f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424170154a465186f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1515","02196","BK1191"],"gpt_icon":0},{"id":"2529667958","title":"时代天使04月24日主力净流出1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2529667958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529667958?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 16:16","pubTimestamp":1745482564,"startTime":"0","endTime":"0","summary":"04月24日, 时代天使股价跌0.20%，报收50.55元，成交金额3037万元，换手率0.36%，振幅3.95%，量比0.91。时代天使今日主力资金净流出1万元，上一交易日主力净流入197万元。该股近5个交易日上涨3.39%，主力资金累计净流出212万元；近20日主力资金累计净流出1234万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424165948a46517c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424165948a46517c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1583","BK1593","06699","BK1587"],"gpt_icon":0},{"id":"2529676700","title":"三生制药04月24日主力净流入4482万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529676700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529676700?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 16:15","pubTimestamp":1745482508,"startTime":"0","endTime":"0","summary":"04月24日, 三生制药股价涨4.53%，报收13.38元，成交金额6.65亿元，换手率2.10%，振幅6.87%，量比1.24。三生制药今日主力资金净流入4482万元，上一交易日主力净流出1740万元。该股近5个交易日上涨6.89%，主力资金累计净流入4568万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入3.15亿元，其中净流入天数为15日。该股主力净额占比0.14%，港股市场排名40/2646。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424165549a46515c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424165549a46515c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01530","BK1593","BK1161"],"gpt_icon":0},{"id":"2529294276","title":"四环医药涨超3%惠升生物研发的达格列净片获国家药监局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2529294276","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529294276?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 15:07","pubTimestamp":1745478420,"startTime":"0","endTime":"0","summary":"四环医药涨超3%，因惠升生物研发的达格列净片获国家药监局批准上市，该药是用于治疗2型糖尿病的SGLT-2抑制剂，市场前景广阔。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042415242497433237&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042415242497433237&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1600","00460","BK1593","BK1191"],"gpt_icon":0},{"id":"2529232926","title":"港股异动 | 四环医药(00460)涨超3% 惠升生物研发的达格列净片获国家药监局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2529232926","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529232926?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 15:07","pubTimestamp":1745478420,"startTime":"0","endTime":"0","summary":"消息面上，四环医药公布，集团旗下非全资附属公司惠升生物制药股份有限公司研发的达格列净片已获国家药品监督管理局颁发的药品注册批件，用于2型糖尿病成人患者，视同通过仿制药品质和疗效一致性评价。达格列净片是惠升生物继脯氨酸加格列净片、恩格列净片后获得上市批准的第三个SGLT-2抑制剂类药物。而2024年达格列净销售额高达约70亿元，行业专家也表示达格列净目前保持着20%–30%的年度增长率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 四环医药(00460)涨超3% 惠升生物研发的达格列净片获国家药监局上市批准","news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1600","BK1515","BK1593","00460","BK1191"],"gpt_icon":0},{"id":"2529616302","title":"三生制药盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529616302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529616302?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 10:10","pubTimestamp":1745460647,"startTime":"0","endTime":"0","summary":"2025年04月24日早盘10时10分，三生制药股票出现异动，股价大幅上涨5.00%。截至发稿，该股报13.440港元/股，成交量1729.83万股，换手率0.72%，振幅5.00%。资金方面，该股资金流入1.309亿港元，流出5655.28万港元。三生制药股票所在的药品行业中，整体涨幅为0.88%。消息层面，截至10时10分，《非执行董事张皎娥减持三生制药2.6万股 每股作价12.94港元》资讯为影响三生制药的重要信息。减持后最新持股数目约为1249.26万股，最新持股比例为0.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504241010489742e2c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504241010489742e2c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1593","BK1161","01530"],"gpt_icon":0},{"id":"2529183876","title":"康哲药业(00867)拟分拆德镁医药上市，业务聚焦推动估值提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2529183876","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529183876?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 09:42","pubTimestamp":1745458940,"startTime":"0","endTime":"0","summary":"智通财经APP了解到，4月22日，康哲药业宣布，建议将旗下皮肤业务子公司德镁医药股份分拆并于香港联交所主板独立上市。康哲药业认为，该分拆完成后，余下集团和分拆集团都将受益，德镁医药预计将可独立进行筹资活动，余下集团将可集中资源发展其核心业务。皮肤健康业务展现强劲增长潜力此次拟分拆上市的德镁医药，业务围绕皮肤处方药及皮肤学级护肤品的研产销，提供从预防、治疗到长期护理的皮肤健康综合解决方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283739.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","SG9999004220.SGD","SG9999015945.SGD","IE00BYV24P56.USD","LU2488822045.USD","SG9999015952.SGD","IE00BMCWC346.EUR","SG9999015986.USD","BK1593","159938","BK1191","BK1515","BK1574","BK1161","SG9999015978.USD","00867"],"gpt_icon":0},{"id":"2529904906","title":"康哲药业分拆“德镁医药”赴港介绍上市，专业聚焦皮肤健康创新药企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2529904906","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529904906?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 09:00","pubTimestamp":1745456407,"startTime":"0","endTime":"0","summary":"摘要：4月22日晚间，康哲药业（0867.HK）发布公告称，拟分拆德镁医药于港交所主板上市，且分拆将以实物方式向股东分派其持有的所有德镁医药股份的方式实施。德镁医药的 90.8%权益由公司实益拥有，其余9.2%权益由两个雇员激励平台持有。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202504_1/49219bd6-08b4-4aad-bc3c-de723ac77fe8.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202504_1/49219bd6-08b4-4aad-bc3c-de723ac77fe8.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/68098d172308299d6cdca96d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["00867","SG9999004220.SGD","SG9999015986.USD","06978","BK1574","IE00BMCWC346.EUR","BK1161","BK1593","LU2488822045.USD","IE00BYV24P56.USD","SG9999015952.SGD","SG9999015945.SGD","SG9999015978.USD","BK1191","BK1515","09939"],"gpt_icon":0},{"id":"2529285696","title":"四环医药：惠升生物研发的达格列净片获国家药监局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2529285696","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529285696?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 08:13","pubTimestamp":1745453580,"startTime":"0","endTime":"0","summary":"　　四环医药发布公告，集团旗下非全资附属公司惠升生物制药股份有限公司研发的达格列净片已获中华人民共和国国家药品监督管理局颁发的药品注册批件，用于2型糖尿病成人患者，视同通过仿制药品质和疗效一致性评价。　　达格列净片为全球首款获批上市的SGLT-2抑制剂。该产品为国家医保产品，国家基本药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-24/doc-ineufnmc3678298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1593","BK1515","BK1191","00460","BK1600"],"gpt_icon":0},{"id":"2529500411","title":"四环医药(00460)：惠升生物研发的达格列净片获国家药监局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2529500411","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529500411?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 20:40","pubTimestamp":1745412034,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四环医药 发布公告，集团旗下非全资附属公司惠升生物制药股份有限公司研发的达格列净片已获中华人民共和国国家药品监督管理局颁发的药品注册批件，用于2型糖尿病成人患者，视同通过仿制药品质和疗效一致性评价。达格列净片为全球首款获批上市的SGLT-2抑制剂。该产品为国家医保产品，国家基本药物。达格列净片是惠升生物继脯氨酸加格列净片、恩格列净片后获得上市批准的第三个SGLT-2抑制剂类药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"四环医药(00460)：惠升生物研发的达格列净片获国家药监局上市批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","00460","BK1191","BK1600","BK1593"],"gpt_icon":0},{"id":"2529502149","title":"现代牙科回购10万股 金额43万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529502149","media":"财中社","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529502149?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 20:03","pubTimestamp":1745409821,"startTime":"0","endTime":"0","summary":"现代牙科（03600）发布公告，2025年4月23日，公司回购股份10万股，回购金额为43万港元。根据回购授权的决议，公司可回购的股份总数为9484万股，已回购股份775万股，占回购授权决议通过时已发行股份的0.817%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504233386058613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1593","BK1100","BK1583","03600"],"gpt_icon":0},{"id":"2529340509","title":"现代牙科(03600)4月23日耗资约42.78万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529340509","media":"智通财经","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529340509?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 19:26","pubTimestamp":1745407599,"startTime":"0","endTime":"0","summary":"智通财经APP讯，现代牙科(03600)公布，2025年4月23日耗资约42.78万港元回购10万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283310.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03600","BK1593","BK1583","BK1100"],"gpt_icon":0},{"id":"2529505467","title":"复星医药(02196)：李东久辞去高级副总裁职务","url":"https://stock-news.laohu8.com/highlight/detail?id=2529505467","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529505467?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 19:02","pubTimestamp":1745406121,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，因到龄退休，李东久向董事会申请辞去高级副总裁职务。李东久自2025年4月23日起不再担任公司高级副总裁职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283279.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0175","BK0060","600196","BK0187","BK0196","BK1593","BK0096","BK0028","BK0183","BK0012","BK1515","02196","BK1191","BK0239","BK0188"],"gpt_icon":0},{"id":"2529398046","title":"复锐医疗科技高管团队一行到访星荣医院 研讨共筑医美产学研医创新高地","url":"https://stock-news.laohu8.com/highlight/detail?id=2529398046","media":"复星医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529398046?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 17:16","pubTimestamp":1745399784,"startTime":"0","endTime":"0","summary":"2025年4月22日，复锐医疗科技有限公司高管团队一行到访复星健康医美旗舰品牌重庆星荣整形外科医院。依托复星全球医疗产业生态资源，星荣整形已构建起集医疗技术、美学设计与科研转化于一体的高端医美服务体系。复锐医疗科技是中国领先的医疗健康产业集团复星医药的控股子公司，于2017年9月在中国香港上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423225317a6c5507f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423225317a6c5507f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","600196","BK1593","01696","BK1100","BK1585"],"gpt_icon":0},{"id":"2529578580","title":"每日卖空追踪 | 康哲药业 04月23日卖空量成交279.8万股，卖空比例为11.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529578580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529578580?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 17:09","pubTimestamp":1745399368,"startTime":"0","endTime":"0","summary":"康哲药业北京时间04月23日，涨4.79%，卖空量成交279.8万股，较上一交易日增加148.05%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423172043a463afce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423172043a463afce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004220.SGD","SG9999015945.SGD","IE00BYV24P56.USD","LU2488822045.USD","SG9999015952.SGD","SG9999015986.USD","BK1593","BK1191","00867","SG9999015978.USD","IE00BMCWC346.EUR"],"gpt_icon":0},{"id":"2529545328","title":"康哲药业分拆“德镁医药”，来自海南海口，拟以介绍方式赴香港上市，递交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2529545328","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529545328?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 13:04","pubTimestamp":1745384640,"startTime":"0","endTime":"0","summary":"　　2025年4月22日，康哲药业分拆德镁医药有限公司Dermavon Holdings Limited在港交所递交上市申请，拟以介绍方式在香港主板上市。　　德镁医药，成立于2020年，总部位于海南海口，作为一家中国领先、专业聚焦皮肤健康的创新型医药企业，围绕皮肤处方药及皮肤学级护肤品的研、产、销一体化运营，致力于提供从预防、治疗到长期护理的皮肤健康综合解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-23/doc-ineucptw3299749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00867","BK1161","SG9999015986.USD","LU2488822045.USD","SG9999015952.SGD","BK1191","SG9999015945.SGD","IE00BMCWC346.EUR","SG9999015978.USD","159938","BK1574","BK1515","SG9999004220.SGD","09939","IE00BYV24P56.USD","BK1593"],"gpt_icon":0},{"id":"2529153095","title":"港股异动 | 时代天使(06699)涨超4% 公司股东李华敏收购上海恺皓40%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2529153095","media":"智通财经","labels":["shareholding","merge","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529153095?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 10:41","pubTimestamp":1745376090,"startTime":"0","endTime":"0","summary":"消息面上，4月22日，时代天使发布公告，上海恺皓已成为公司的关联人士，原因是公司主要股东李华敏已收购上海恺皓总股权的40%。因此，上海恺皓与公司之间的加工承包协议项下的持续交易已成为公司的持续关联交易。加工承包协议于2024年10月28日签订，主要条款包括上海恺皓根据无锡时代天使的购买订单提供原材料加工服务，协议有效期至2025年12月31日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","06699","BK1100","BK1583","BK1593"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":108,"code":"91000000","status":"200"}]}}